Informations:
Erreur:
ID
17243
Description
Concurrent Pemetrexed, Cisplatin and Radiation Therapy in Patients With Stage IIIA/B Non Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00529100
Lien
https://clinicaltrials.gov/show/NCT00529100
Mots-clés
Versions (1)
- 01/09/2016 01/09/2016 -
Téléchargé le
1 septembre 2016
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Non-Small Cell Lung Cancer NCT00529100
Eligibility Non-Small Cell Lung Cancer NCT00529100
- StudyEvent: Eligibility
Similar models
Eligibility Non-Small Cell Lung Cancer NCT00529100
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Inclusion Criteria
Item
some of the requirements to be in this study are:
boolean
C1512693 (UMLS CUI [1])
Age
Item
patient must be at least 18 years old.
boolean
C0001779 (UMLS CUI [1])
Non-small cell lung cancer
Item
patient must have been diagnosed with non-small cell lung cancer.
boolean
C0007131 (UMLS CUI [1])
Office Visits
Item
patient must be able to visit the doctor's office once a week.
boolean
C0028900 (UMLS CUI [1])
Blood, liver, lung and kidney function
Item
patient must have adequate blood, liver, lungs and kidney function within the requirements of this study.
boolean
C0005811 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
C0231921 (UMLS CUI [3])
C0232804 (UMLS CUI [4])
C0232741 (UMLS CUI [2])
C0231921 (UMLS CUI [3])
C0232804 (UMLS CUI [4])
Serum pregnancy test, Contraception
Item
female patients of child-bearing potential must test negative for pregnancy at the time of enrollment based on a serum pregnancy test. male and female patients must agree to use a reliable method of birth control during and for 3 months following the last dose of study drug.
boolean
C0430060 (UMLS CUI [1])
C0700589 (UMLS CUI [2])
C0700589 (UMLS CUI [2])
Exclusion Criteria
Item
patients cannot participate in this study for any of the following reasons:
boolean
C0680251 (UMLS CUI [1])
Previous chemotherapy
Item
patient has previously had chemotherapy.
boolean
C0392920 (UMLS CUI [1])
previous thoracic radiation therapy
Item
patient has previously had thoracic radiation therapy.
boolean
C4038705 (UMLS CUI [1])
Investigational drug
Item
patient has received treatment within the last 30 days with a drug that has not received approval by health canada for any indication at the time of study entry.
boolean
C0013230 (UMLS CUI [1])
Pregnancy or breast feeding
Item
female patient is pregnant or breast-feeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Compliance behavior
Item
patient is unsuitable to participate in the study in the opinion of the investigator.
boolean
C1321605 (UMLS CUI [1])
unable or unwilling to take folic acid, vitamin b12 supplementation, or dexamethasone
Item
patient is unable or unwilling to take folic acid, vitamin b12 supplementation, or dexamethasone.
boolean
C0556110 (UMLS CUI [1])
C3661610 (UMLS CUI [2])
C0011777 (UMLS CUI [3])
C3661610 (UMLS CUI [2])
C0011777 (UMLS CUI [3])